Mobilelime Inc., a Watertown, Mass.-based provider of software that lets consumers to make purchases via mobile phones, has acquired Cuesol Inc., a Quincy, Mass.
Chef Solutions Inc., a portfolio company of Questor Management Co., has sold wholly-owned subsidiary I&K Distributors Inc. to Countryside Foods LLC, an entity controlled by private equity sponsor Ramex Inc. I&K products include Yoders deli salads and side dishes and Michigan Brand cottage cheese. No financial terms were disclosed for the deal, on which Chef […]
Optium Corp. (Nasdaq: OPTM), a Chalfont, Pa.-based maker of optical subsystems for use in telecom network systems, has agreed to acquire Kailight Photonics Inc., an Israel-based provider of 40Gb/s optical transmission products. The deal includes a $35 million up-front cash payment, plus a stock earnout of up to $5 million. Kailight has raised around $12.1 […]
Leonard Green & Partners of Los Angeles has closed its fifth buyout fund with $5.3 billion in capital commitments. Buyouts Magazine reported the fund close on its website earlier this week
NanoDimension, a Zurich-based VC firm focused on nanotech opportunities, has closed its inaugural fund with Euro 45 million in capital commitments. www.nanodimension.com
Ziegler Meditech Partners, a joint venture between Ziegler Cos. and Medtech Advisors LLC, has closed its inaugural venture fund with $52.7 million, according to VentureWire. The fund will focus on mid-to-late stage medical device companies in the U.S. and Israel. www.zmep.com
Dr. Lara Sullivan has joined the healthcare team of Paul Capital Partners as a New York-based principal, effective April 23. She previously was in the pharma and medical products practice of McKinsey & Company. www.paulcapitalhealthcare.com
Joseph Pescatore has joined Jefferies Asset Management as director of marketing. He previously helped Energy Capital Partners raise fund capital. www.jefferies.com
Terry Tian has joined Chicago-based turnaround firm Lake Pointe Partners as an associate in the firm's new Shanghai office. www.lakepointepartners.com
MAP Pharmaceuticals Inc., a Mountain View, Calif.-based developer of inhaled drug products for respiratory and CNS diseases, has raised has raised $50 million in Series D funding. D.E. Shaw Group was joined by return backers Perseus-Soros Biopharmaceutical Fund, Pequot Ventures, Brookside Capital and Skyline Ventures. MAP Pharma has raised around $107 million in total VC […]